Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial.

Bramwell, Vivien H C; Tuck, Alan B; Chapman, Judith-Anne W; Anborgh, Pieter H; Postenka, Carl O; Al-Katib, Waleed; Shepherd, Lois E; Han, Lei; Wilson, Carolyn F; Pritchard, Kathleen I; Pollak, Michael N; Chambers, Ann F

Bramwell, Vivien H C; Tuck, Alan B; Chapman, Judith-Anne W; Anborgh, Pieter H; Postenka, Carl O; Al-Katib, Waleed; Shepherd, Lois E; Han, Lei; Wilson, Carolyn F; Pritchard, Kathleen I; Pollak, Michael N; Chambers, Ann F.

Breast Cancer Res ; 16(1): R8, 2014 Jan 22.

Article in En | MEDLINE | ID: mdl-24451146

Subject(s)

Biomarkers, Tumor/blood; Breast Neoplasms/blood; Neoplasm Recurrence, Local/blood; Osteopontin/blood; Antineoplastic Agents, Hormonal/therapeutic use; Breast Neoplasms/drug therapy; Breast Neoplasms/surgery; Disease-Free Survival; Female; Humans; Middle Aged; Octreotide/therapeutic use; Tamoxifen/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Osteopontin / Neoplasm Recurrence, Local Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google